EUVIMEDEUVIMED entdecken
Multizentrische Studie

Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study

Manman Li, Shu Jiang, Siyu Zhou, Wang Chen, Yong Xiao, Yigang Fu, Feng Feng, Guodong Xu

Abdominal Radiology · 2025

DOI: 10.1007/s00261-025-04912-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Manman Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tomography, X-Ray Computed, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Jiangsu Provincial Health Commission, the Key Research and Development Program (Social Development) of the Yancheng Science and Technology Bureau, Yancheng Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This research investigated the potential of CT-based radiomics analysis for predicting human epidermal growth factor receptor 2 (HER2) status and assessing the prognosis of patients with gastric cancer (GC). METHODS: 431 patients with GC from two medical centers were included in this retrospective study, with patients allocated to a training cohort (n = 221), a testing cohort (n = 94), and an external validation cohort (n = 116). Radiomics features and clinical variables associated with HER2 status were identified, and the radiomics score was subsequently derived. A radiomics model was constructed using the radiomics score, and a nomogram was developed by integrating related variables. The predictive accuracy of models was assessed via receiver operating characteristic curves, with the area under the curve (AUC) being computed. Prognostic significance was assessed by exploring the association between nomogram-predicted HER2 status and overall survival (OS). RESULTS: The radiomics model yielded AUCs of 0.801, 0.793, and 0.784 for the training, testing, and external validation cohorts, respectively. A nomogram that integrated sex, CA72-4 levels, and radiomics score exhibited enhanced predictive accuracy, achieving AUCs of 0.847, 0.836, and 0.828 across the cohorts. Decision curve analysis highlighted the clinical utility of the nomogram, illustrating its ability to deliver a higher net benefit. In addition, survival analysis indicated that individuals with nomogram-predicted HER2 positivity experienced significantly shorter OS, providing robust risk stratification and prognostic insights. CONCLUSION: The CT-based radiomics nomogram demonstrated the ability to non-invasively predict preoperative HER2 status and stratify prognostic risk in this GC cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTomography, X-Ray ComputedErb-b2 Receptor Tyrosine KinasesHumansFemaleRetrospective StudiesMalePrognosisMiddle AgedAgedNomogramsAdultRadiomics

Stichwörter der Autor:innen

Computed tomographyGastric cancerHuman epidermal growth factor receptor 2Radiomics

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, China.
  • Affiliated Tumor Hospital of Nantong University, Nantong, China.
  • Affiliated Tumor Hospital of Nantong University, Nantong, China. fengfeng@ntu.edu.cn.
  • The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, China. xgd20133@163.com.
  • the Third Affiliated Hospital of Soochow University, Changzhou, China. xgd20133@163.com.

Förderung

  • Jiangsu Provincial Health Commission
  • the Key Research and Development Program (Social Development) of the Yancheng Science and Technology Bureau
  • Yancheng Health Commission

Zitieren

APA

Li, M., Jiang, S., Zhou, S., Chen, W., Xiao, Y., Fu, Y., Feng, F., & Xu, G. (2025). Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study. Abdominal Radiology. https://doi.org/10.1007/s00261-025-04912-0

Vancouver

Li M, Jiang S, Zhou S, Chen W, Xiao Y, Fu Y, et al. Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study. Abdominal Radiology. 2025. doi:10.1007/s00261-025-04912-0

BibTeX
@article{Li2025,
  author = {Li, Manman and Jiang, Shu and Zhou, Siyu and Chen, Wang and Xiao, Yong and Fu, Yigang and Feng, Feng and Xu, Guodong},
  title = {Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study},
  journal = {Abdominal Radiology},
  year = {2025},
  doi = {10.1007/s00261-025-04912-0}
}
Kostenlos starten →